Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US1510201049
Ticker CELG
Company CELGENE
Currency $
Price
Aware Investor Index (AII) 0.0574
Recommendation SELL
P/E 122.30
ROE 13.93 %
Capitalization 100,835,776,000 $
Dividend Yield 0.00 %
P/S 10.89
AII Position 531
P/E Position 733
ROE Position 278
Capitalization Position 82
Dividend Yield Position 629
Sales 9,256,000,000 $
10-Year Average Earnings 824,515,000 $
Shares Outstanding 824,900,000
Equity 5,919,000,000 $
Dividend per Share 0 $
Industry Biotechnology
Country United States
CELGENE Investor Relations Web Site http://ir.celgene.com







Sales:

YEAR MONTH AMOUNT
2015 12 9,256,000,000.00 $
2014 12 7,670,400,000.00 $
2013 12 6,493,900,000.00 $

Earnings:

YEAR MONTH AMOUNT
2015 12 1,602,000,000.00 $
2014 12 1,999,900,000.00 $
2013 12 1,449,900,000.00 $
2012 12 1,456,180,000.00 $
2011 12 1,318,150,000.00 $
2010 12 880,512,000.00 $
2009 12 776,747,000.00 $
2008 12 -1,533,653,000.00 $
2007 12 226,433,000.00 $
2006 12 68,981,000.00 $

Equity:

YEAR MONTH AMOUNT
2015 12 5,919,000,000.00 $
2014 12 6,524,800,000.00 $
2013 12 5,589,900,000.00 $
2012 12 5,694,467,000.00 $
2011 12 5,512,727,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2015 12 824,900,000
2014 12 836,000,000
2013 12 430,300,000
2012 12 440,796,000
2011 12 422,987,284

 












Bloomberg News for CELGENE:

Jul 26, 2017
U.S. Equities Steady as Investors Await Fed; Tech Shares Higher
Helmerich & Payne Inc (HP), PG&E Corp (PCG), Comcast Corp (CMCSA), BorgWarner Inc (BWA),Celgene Corp (CELG), Johnson Controls International plc (JCI), Xcel Energy Inc (XEL),L3 Technologies Inc (LLL), Boston...
Aug 4, 2010
Arbitrage Profit in U.S. Takeovers Pending on Aug. 4
08/25/10 ARG US APD US 63.50 65.30 -1.80 -2.76 77,416 Cash 08/13/10 ABII US CELG US 72.75 75.78 -3.03 -3.99 2,776 C&S 12/31/10 CASY US ATD/B CN 36.75 ...
Feb 10, 2012
Nasdaq Short Interest as of Jan. 31
642 5,536 CECE CECO ENVIRONMNTL 6,147 7,504 31,975 CELG CELGENE CORP 7,920,994 9,159,230 3,595,048 CELGZ CELGENE CORP-CVR...
Jul 28, 2011
Midmorning Positive EPS Surprises for U.S. Companies, July 28
8.5 0.49 4.1 Jun DRE DUKE REALTY CORP 0.29 0.29 0.0 0.28 3.6 Jun CELG* CELGENE CORP 0.89 0.69 29.0 0.86 3.5 Jun K* KELLOGG CO ...
May 16, 2011
Orbimed Advisors LLC Holdings in 1st Quarter: 13F Alert
Inc. MRK US -36,115,810 2,505,000 -791,500 Celgene Corp CELG US -26,658,968 490,400 -437,800 Thermo Fisher Scientific Inc TMO US -24,391...
Jan 21, 2011
S&P 500 Stocks With Biggest Gap Between Market Price, Estimate
15.30 19.39 -8.43 BAC BANK OF AMERICA 26.4 23 14.34 18.13 -11.57 CELG CELGENE CORP 26.2 22 56.37 71.14 -2.40 GME GAMESTOP CORP-A 25...
Jan 7, 2011
S&P 500 Stocks With Biggest Gap Between Market Price, Estimate
46.18 55.88 -2.48 JPM JPMORGAN CHASE 20.8 22 43.28 52.30 1.77 CELG CELGENE CORP 20.8 22 59.34 71.68 4.61 CSCO CISCO SYSTEMS 20...
Jan 13, 2010
North and South American Stock Rating Changes, New Coverage
-------------------------------------------------------------------------------- Celgene Corp (CELG US) EVA Dimensions Analyst Recommendation Action Target Team Coverage ...
Jun 17, 2010
50 Top Performers
from Apple (AAPL) (No. 4) and Google (GOOG) (No. 16) to biotechnology players such as Celgene (CELG) (No. 13) and Gilead Sciences (GILD) (No. 26), a leader in drugs to fight HIV. The big surprise...
Jun 13, 2005
Online Extra: The Next Wave
application must be reviewed within six months after it's filed. Revlimid Celgene (CELG ) Myelodysplastic syndrome (MDS), a malignant blood-cell disorder that causes anemia...


Google News for CELGENE:

Nasdaq - 24 Jul 2017
Is Celgene (CELG) Poised For a Beat This Earnings Season?
Celgene Corporation CELG is scheduled to report second-quarter 2017 results on Jul 27, before the opening bell. Last quarter, the company ...
Seeking Alpha - 10 Aug 2017
A Celgene-Ius Investment
Celgene's key revenue driver is the continued success in Revlimid. Rather alarmingly, it contributed to over 62% of the company's total revenue ...
Seeking Alpha - 27 Jul 2017
Celgene: Expect The Story To Continue
The growth story at Celgene (CELG) continues and has the potential to give investors new all-time highs in the near future. As the stock is not ...
Nasdaq
The Celgene Story Is Bigger Than Revlimid Now; Argus Upgrades
Argus upgraded Celgene Corporation (NASDAQ: CELG) Monday on the strength of a diversified drug portfolio and a “robust development ...
Zacks.com
Drilling Down Into Celgene Corporation (CELG)
Celgene Corporation (CELG) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the ...
StreetInsider.com
Celgene Paves The Way For Rare AML Patients
Recently, Celgene (CELG) and its partner Agios Pharmaceuticals (AGIO) announced that the FDA has approved enasidenib (AG-221) for ...
Benzinga - 31 Jul 2017
Celgene slips 3% on modified oncology deal with Sutro
The market's down day notwithstanding, Celgene (CELG -2.8%) retreats on light volume on the heels of its revised immuno-oncology ...
StockNewsJournal - 2 days ago
How 2 biotech partners reimagined cancer pact — and made it work ...
The small South San Francisco company and the Big Biotech player had different objectives when they reworked their three-year-old deal.
TrueBlueTribune
Celgene: Gearing Up For New Highs
Not only does Celgene (CELG) boast beefy levels of earnings growth, it's also emerging from a base that's nearly two years in the making.
ExpressNewsline
RidgeWorth Capital Management LLC Maintains Position in ...
Celgene Corporation logo RidgeWorth Capital Management LLC maintained its stake in Celgene Corporation (NASDAQ:CELG) during the first ...


Back